Holen Sie sich die Stockscreener-App
35.07
0.45%
-0.16
Handel nachbörslich:
35.17
0.10
+0.29%
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages - marketbeat.com
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo! Finance Canada
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a High Forward P/E Amid Robust Growth in the Healthcare Sector - DirectorsTalk Interviews
BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month HighTime to Buy? - marketbeat.com
BioLife Solutions Cut to Hold From Buy by Benchmark - moomoo.com
Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next - simplywall.st
BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit - simplywall.st
BioLife Solutions Inc (BLFS) Stock News Today - TradingKey
Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS - marketbeat.com
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 ProfitWhat's Changed - Yahoo Finance
Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS - MarketBeat
BLFS Technical Analysis & Stock Price Forecast - Intellectia AI
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
BioLife Solutions, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions 2026: Revenue $28.47M, EPS $0.91— 10-Q Summary - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M - marketscreener.com
BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen - Stock Titan
BioLife Solutions reports Q2 2026 revenue $28.5M, GAAP net income $45.1M, adjusted EBITDA $7.4M - TradingView
BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioLife Solutions (NASDAQ:BLFS) Hits New 52-Week HighStill a Buy? - MarketBeat
BioLife Solutions set to report earnings under takeover cloud By Investing.com - Investing.com Nigeria
Biolife Solutions stock hits 52-week high at 33.18 USD - Investing.com
Biolife Solutions stock hits 52-week high at 33.18 USD By Investing.com - Investing.com South Africa
Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - stocktitan.net
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector - DirectorsTalk Interviews
Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline - TradingView
BioLife Solutions (BLFS) to Post Earnings on Thursday - marketbeat.com
Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com South Africa
Biolife Solutions stock hits 52-week high at 32.24 USD - Investing.com
BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month HighStill a Buy? - marketbeat.com
BLFS|BioLife Solutions Inc|Price:29.950|Chg%:-0.030 - TradingKey
BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HC Wainwright Expects Higher Earnings for BioLife Solutions - marketbeat.com
BioLife Solutions Inc (BLFS) Income Statement - tradingkey.com
BioLife Solutions Inc (BLFS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BLFS|BioLife Solutions Inc|Price:29.980|Chg%:-0.790 - TradingKey
BioLife Solutions Inc (BLFS) Institutional Confidence - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1 - TradingView
BioLife Solutions (NASDAQ:BLFS) Stock Rating Lowered by Wall Street Zen - marketbeat.com
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc.BLFS - Business Wire
Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan
BIOLIFE SOLUTIONS INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $31 FROM $30 - Bitget
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition - Sahm
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - TradingView
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30 - Moomoo
BioLife Solutions (NASDAQ:BLFS) Sees Strong Trading VolumeWhat's Next? - marketbeat.com
BIOLIFE SOLUTIONS INC : TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $31 FROM $33 - Bitget
Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals
Repligen Corporation (RGEN) BioLife Solutions, Inc.,M&A CallSlideshow (NASDAQ:RGEN) 2026-07-23 - Seeking Alpha
Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Leadership in Cell Therapy Market - Minichart
BioLife Solutions Inc (BLFS) Stock Up 6.8% but GF Value Says Ove - GuruFocus
BioLife Solutions Cut to Hold From Buy by Lake Street - Moomoo
BioLife Solutions to Be Acquired by Repligen Corporation - TipRanks
Repligen to Acquire Bothell's BioLife Solutions in $1.5B Deal - 425business.com
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share - TradingView
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-stock deal - Stock Titan
Repligen to Acquire BioLife Solutions for $11.25 per Share Plus Stock, Enhancing Cell Processing Capabilities - Kalkine Media
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Yahoo Finance
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) - PR Newswire
Repligen targets cell therapy expansion as Waltham firm inks $1.5 billion acquisition - The Business Journals
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):